Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 51,571,939
- Total 13F shares
- 41,248,927
- Share change
- +10,843,942
- Total reported value
- $745,334,512
- Put/Call ratio
- 167%
- Price per share
- $18.07
- Number of holders
- 100
- Value change
- +$197,052,931
- Number of buys
- 68
- Number of sells
- 35
Report period
Q2 2023
Institutions
100
Top holders
10
FDMT full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 35104E100
Recent filing periods:
Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
7.8%
|
4,007,413
|
$68,887,429 | — | 31 Mar 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
7.6%
|
3,937,914
|
$67,692,742 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
2,550,735
|
$43,847,134 | — | 31 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
4.4%
|
2,278,107
|
$39,160,659 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
2,042,189
|
$35,105,229 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
1,877,425
|
$32,285,534 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
3.4%
|
1,741,877
|
$29,942,867 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,545,884
|
$26,573,745 | — | 31 Mar 2023 | |
| Casdin Capital, LLC |
13F
|
Company |
2.1%
|
1,070,000
|
$18,393,300 | — | 31 Mar 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2%
|
1,032,719
|
$17,752,440 | — | 31 Mar 2023 | |
| Novo Holdings A/S |
13F
|
Company |
1.4%
|
700,000
|
$12,033,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
577,922
|
$9,934,485 | — | 31 Mar 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.97%
|
499,996
|
$8,594,931 | — | 31 Mar 2023 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.92%
|
472,500
|
$8,122,275 | — | 31 Mar 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.91%
|
469,400
|
$8,068,986 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.85%
|
440,313
|
$7,569,000 | — | 31 Mar 2023 | |
| Eagle Health Investments LP |
13F
|
Company |
0.85%
|
437,911
|
$7,527,690 | — | 31 Mar 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.61%
|
314,000
|
$5,397,660 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.57%
|
294,000
|
$5,053,860 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
274,429
|
$4,717,434 | — | 31 Mar 2023 | |
| Perigon Wealth Management, LLC |
13F
|
Company |
0.48%
|
246,075
|
$4,230,029 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.46%
|
235,000
|
$3,718,211 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
218,106
|
$3,749,242 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.41%
|
208,900
|
$3,590,991 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.39%
|
200,883
|
$3,453,179 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
197,802
|
$3,400,216 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
192,883
|
$3,315,660 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.34%
|
175,516
|
$3,017,120 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.3%
|
156,631
|
$2,693,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
146,958
|
$2,526,208 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.26%
|
134,788
|
$2,317,006 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
112,098
|
$1,926,965 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.22%
|
111,678
|
$1,919,745 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
108,455
|
$1,864,341 | — | 31 Mar 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.2%
|
104,753
|
$1,800,704 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.19%
|
100,000
|
$1,719,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.16%
|
81,457
|
$1,400,246 | — | 31 Mar 2023 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.16%
|
80,529
|
$1,384,294 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
80,267
|
$1,379,790 | — | 31 Mar 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
80,029
|
$1,375,699 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.15%
|
78,574
|
$1,350,687 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
61,358
|
$1,054,744 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
57,229
|
$983,766 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
52,399
|
$900,739 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
48,799
|
$838,855 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
47,501
|
$817,000 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
38,500
|
$661,815 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.07%
|
33,954
|
$583,669 | — | 31 Mar 2023 | |
| M&T BANK CORP |
13F
|
Company |
0.06%
|
28,814
|
$495,656 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
27,988
|
$481,114 | — | 31 Mar 2023 |
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) as of Q2 2023
As of 30 Jun 2023,
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,248,927 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., VR Adviser, LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, STATE STREET CORP, VANGUARD GROUP INC, and MORGAN STANLEY.
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
94
Q2 2023 holders
100
Holder diff
6
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.